Filing Details
- Accession Number:
- 0001005201-19-000045
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-18 08:01:51
- Reporting Period:
- 2019-03-14
- Accepted Time:
- 2019-03-18 08:01:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1005201 | Assertio Therapeutics Inc | ASRT | Pharmaceutical Preparations (2834) | 943229046 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1663041 | Stan Bukofzer | Assertio Therapeutics, Inc. 100 South Saunders Road, Suite 300 Lake Forest IL 60045 | Svp, Chf Scitfc & Tech Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-03-14 | 5,000 | $4.13 | 5,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported is a weighted average purchase price. The shares were purchased in multiple same-way transactions on March 14, 2019 at prices ranging from $4.123 to $4.133 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock purchased at each separate price.